Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$27,604,950
-$6,345,898 QoQ
Shares Held
780,683
-35.7% QoQ
Ownership
0.468%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 98.59097738774894.ToString("F0")%
Shared 0.ToString("F0")%
None 1.4090226122510672.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Derivatives in ALKS
reported options exposure · as of Sep 30, 2021CallValue
$320,736
CallShares
10,400
PutValue
$240,552
PutShares
7,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $750,878,580 across 46 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,060,570 | $403,199,491 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,392,628 | $60,857,818 | |
| 3 | ALKS |
Alkermes plc.
This page
|
780,683 | $27,604,950 | |
| 4 | ESPR |
Esperion Therapeutics, Inc.
|
9,458,779 | $25,917,054 | |
| 5 | LQDA |
Liquidia Corp
|
563,233 | $21,256,413 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
5,848,276 | $20,527,448 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
420,914 | $20,267,009 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
590,116 | $19,515,136 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,604,950 | 780,683 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $33,950,848 | 1,213,397 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,694,970 | 656,499 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,324,084 | 325,903 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,423,178 | 557,940 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,448,235 | 328,520 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,354,395 | 405,659 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,897,393 | 78,730 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,952,489 | 293,775 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,891,444 | 428,675 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $33,309,183 | 1,189,189 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $29,569,704 | 944,719 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,351,094 | 473,611 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $23,528,366 | 900,435 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,657,644 | 522,062 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,347,407 | 347,345 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,159,434 | 234,110 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,314,939 | 185,509 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,723,756 | 477,424 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $240,552 | 7,800 | Put | Sole | 2021-11-15 | |
| 2021-09-30 | $320,736 | 10,400 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $12,567,603 | 512,545 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $5,297,024 | 265,515 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $9,670,799 | 498,238 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $14,867,221 | 1,031,014 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||